SMAD4 and familial pancreatic carcinoma: Finally, loss of nuclear [32] or loss of both nuclear and cytoplasmic [33] expression of mothers against decapentaplegic homolog 4 (SMAD4), but also positive nuclear SMAD4 staining [34], has been reported to be of potential value to distinguish mainly pancreatic cancer from non-GI cancers.